Public Health

The U.S. Food and Drug Administration is alerting patients of a safety concern regarding diabetes devices, such as continuous glucose monitors (CGMs), insulin pumps and automated insulin dosing systems, that rely on a smartphone to deliver critical safety alerts.

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults.

From January 20 to 22, 2025, the National Weather Service (NWS) is forecasting extreme cold for Pennsylvania (PA). Exposure to extreme cold can cause multiple health effects including hypothermia and frostbite.